Adjuvanted and high-dose flu vaccines show similar efficacy in preventing infection and hospitalization in US adults aged 65 and older.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
Both the CDC and WHO say preliminary UK data show the current flu vaccine offers strong protection against subclade K.
Researchers identify nearly 5 excess cardiovascular events per 100 patients in the year after diagnosis.
Mexico has reported 92 cases of myiasis caused by New World screwworm as of November.
Current US hot spots are Utah, Arizona, and South Carolina.
Only 1 state—Louisiana—reported high influenza-like illness.
Only 3 states report moderate levels of acute respiratory illnesses.
The CDC has closed its investigation into a Salmonella outbreak linked to eggs that sickened 105 people in 14 states.
In a phase 3 trial, participants who received the shot were 29% less likely to be diagnosed with flu than those who received a conventional flu shot.
This is the 18th case of human H5N1 avian flu in Cambodia this year.
Early data from the UK and Japan show that the H3N2 subclade K was represented in 90% of flu samples.
